Morgan Stanley
AMPE

Morgan Stanley’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Morgan Stanley’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,809
Closed -$7.18K – 8097
2024
Q1 		$7.18K Buy
7,809
+2,295
+42% +$3.97K ﹤0.01% 6802
2023
Q4 		$11.3K Buy
5,514
+5,247
+1,965% +$13.6K ﹤0.01% 6808
2023
Q3 		$972 Buy
267
+2
+0.8% +$9 ﹤0.01% 7238
2023
Q2 		$1.23K Buy
265
+86
+48% +$421 ﹤0.01% 7269
2023
Q1 		$834 Buy
179
+1
+0.6% +$6 ﹤0.01% 7376
2022
Q4 		$800 Sell
178
-177
-50% -$1.14K ﹤0.01% 7501
2022
Q3 		$6K Sell
355
-677
-66% -$23.7K ﹤0.01% 7233
2022
Q2 		$52K Buy
1,032
+709
+220% +$52.8K ﹤0.01% 6597
2022
Q1 		$46K Sell
323
-6
-2% -$876 ﹤0.01% 6756
2021
Q4 		$55K Sell
329
-150
-31% -$55.9K ﹤0.01% 6773
2021
Q3 		$237K Buy
479
+40
+9% +$18.5K ﹤0.01% 5903
2021
Q2 		$220K Sell
439
-73
-14% -$39.2K ﹤0.01% 5963
2021
Q1 		$260K Buy
512
+168
+49% +$86.6K ﹤0.01% 5503
2020
Q4 		$165K Buy
344
+71
+26% +$23.3K ﹤0.01% 5685
2020
Q3 		$78K Buy
273
+202
+285% +$50.1K ﹤0.01% 5541
2020
Q2 		$13K Buy
71
+7
+11% +$1.16K ﹤0.01% 6111
2020
Q1 		$8K Buy
64
+7
+12% +$1.27K ﹤0.01% 6092
2019
Q4 		$10K Sell
57
-14
-20% -$1.81K ﹤0.01% 6267
2019
Q3 		$11K Sell
71
-429
-86% -$57.2K ﹤0.01% 6182
2019
Q2 		$58K Buy
500
+421
+533% +$66.7K ﹤0.01% 5549
2019
Q1 		$14K Sell
79
-637
-89% -$109K ﹤0.01% 6116
2018
Q4 		$85K Sell
716
-281
-28% -$43.1K ﹤0.01% 5609
2018
Q3 		$151K Buy
997
+285
+40% +$119K ﹤0.01% 5562
2018
Q2 		$469K Sell
712
-90
-11% -$67.3K ﹤0.01% 5153
2018
Q1 		$818K Buy
802
+778
+3,242% +$651K ﹤0.01% 4696
2017
Q4 		$30K Buy
24
+8
+50% +$3.76K ﹤0.01% 5976
2017
Q3 		$3K Sell
16
-294
-95% -$46.5K ﹤0.01% 6376
2017
Q2 		$48K Buy
310
+77
+33% +$15.6K ﹤0.01% 5872
2017
Q1 		$56K Sell
233
-265
-53% -$71.2K ﹤0.01% 5799
2016
Q4 		$135K Buy
498
+445
+840% +$106K ﹤0.01% 5481
2016
Q3 		$12K Sell
53
-51
-49% -$14.3K ﹤0.01% 6077
2016
Q2 		$40K Hold
104
– – ﹤0.01% 5601
2016
Q1 		$71K Buy
104
+10
+11% +$6.74K ﹤0.01% 5470
2015
Q4 		$99K Sell
94
-114
-55% -$113K ﹤0.01% 5413
2015
Q3 		$181K Sell
208
-22
-10% -$18.4K ﹤0.01% 5135
2015
Q2 		$163K Sell
230
-130
-36% -$139K ﹤0.01% 5341
2015
Q1 		$814K Sell
360
-439
-55% -$748K ﹤0.01% 4289
2014
Q4 		$823K Buy
799
+86
+12% +$91.9K ﹤0.01% 4309
2014
Q3 		$755K Buy
713
+633
+791% +$1.07M ﹤0.01% 4282
2014
Q2 		$201K Sell
80
-187
-70% -$382K ﹤0.01% 5158
2014
Q1 		$509K Buy
267
+163
+157% +$385K ﹤0.01% 4538
2013
Q4 		$223K Sell
104
-98
-49% -$232K ﹤0.01% 4971
2013
Q3 		$455K Buy
+202
New +$391K ﹤0.01% 4400

Other funds holding AMPE

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SWM
Sanctuary Wealth Management Pocatello, Idaho $151M AUM 17.94% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Morgan Stanley's AMPE Position: Q2 2024 in Review

Morgan Stanley sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 7,809 shares — an estimated $7.18K sold.

Morgan Stanley first reported a position in AMPE in Q3 2013 and held it in 43 quarters. The position peaked at $823K in Q4 2014. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

  • Morgan Stanley reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 7,809 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $7.18K.
  • Morgan Stanley first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 43 quarters.
  • Morgan Stanley's Ampio Pharmaceuticals Inc. position peaked at $823K in Q4 2014.
  • 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.